Condensed Consolidated Statement of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net loss	$ (592,593)	$ (74,778)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	9,488	5,629
Stock-based compensation	652,821	118
Loss on equity method investments	20,887	28,624
Gain on investments	(450)	(12,622)
Changes in Fair Value of Loans Receivable	(584)	1,825
Change in fair value of warrant liabilities	(85,035)	0
Change in fair value of contingent consideration liability	1,513	0
Gain on deconsolidation of subsidiary (Note 4)	(15,900)	0
Other non-cash activity	104	0
Changes in operating assets and liabilities:
Accounts receivable, net from related parties	(34,928)	(9,541)
Prepaid expenses and other current assets	700	1,633
Inventory, net	(5,335)	(681)
Other non-current assets	2,212	(678)
Accounts payable	26,250	516
Accrued expenses and other current liabilities	9,973	16,807
Deferred revenue, current and non-current (($9,702) and ($6,491) from related parties)	11,444	(5,512)
Deferred rent, non-current	516	688
Other non-current liabilities	(20,981)	(159)
Net cash used in operating activities	(19,898)	(48,131)
Cash flows from investing activities:
Purchases of property and equipment	(3,580)	(21,935)
Prepayment for marketable equity securities	(3,691)	0
Deconsolidation of subsidiary - cash	(28,772)	0
Prepayment for business acquisition		(1,210)
Other	58	99
Net cash used in investing activities	(35,985)	(23,046)
Cash flows from financing activities:
Proceeds from exercise of stock options	75	27
Taxes paid related to net share settlement of equity awards	(981)	0
Principal payments on capital leases and lease financing obligation	(286)	(285)
Payment of deferred offering costs		(175)
Net cash provided by financing activities	(1,192)	(433)
Effect of foreign exchange rates on cash and cash equivalents	(8)
Net increase (decrease) in cash, cash equivalents and restricted cash	(57,083)	(71,610)
Cash and cash equivalents, beginning of period	1,550,004	380,801
Restricted cash, beginning of period	42,924	5,076
Cash, cash equivalents and restricted cash, beginning of period	1,592,928	385,877
Cash and cash equivalents, end of period	1,492,971	308,128
Restricted cash, end of period	42,874	6,139
Cash, cash equivalents, and restricted cash, end of period	1,535,845	314,267
Supplemental disclosure of non-cash financing activities:
Purchases of equipment through capital leases	770	3,175
Purchases of property and equipment included in accounts payable and accrued expenses	5,017	15,324
Equity received in related parties	0	24,595
Warrants received for Foundry services	543	0
Lease financing obligation for build-to-suit lease	5,134	0
Loans receivable issued for Foundry services	4,189	0
Deferred offering costs in accounts payable and accrued expense		$ 2,288